NeoGenomics' GAAP loss for 3 months of 2022 was $49.408 million, up 2.3 times from $22.114 million in the previous year. Revenue increased 1.4% to $117.169 million from $115.533 million a year earlier.
NeoGenomics' GAAP loss for 3 months of 2022 was $49.408 million, up 2.3 times from $22.114 million in the previous year. Revenue increased 1.4% to $117.169 million from $115.533 million a year earlier. 
ir.neogenomics.com
English (US) 